More than two decades ago, Kuivaniemi et al. [45] observed deficient LOX production in a variety of malignant transformed cells, such as HT-1080 (fibrosarcoma), A-204 (rhabdomyosarcoma) or G-361 (melanoma). The gene discussed is LOX; the disease is melanoma.